Yes we are in the biggest double blind study in human history.....

First 24 Last

Share
Profile

Follow
snowvistaman

577 Posts.

65

12/07/21

15:51

Post #: 54446613
Share

Originally posted by Bylosellhi: ↑

A FDA bridging study is a study performed in a new region to provide pharmacodynamic or clinical data on efficacy, safety, dosage and dose regimen that will allow extrapolation of foreign clinical data to the population in the new region.For example if the FDA fast tracks EFTI for HNSCC and we get approval, we still don't have a breast cancer indication.

We do know that certain breast cancer subsets do extremely well with EFTI. Initially in Spring 2020 Immutep reported "Efti did not prolong overall median PFS in women with HR+ MBC receiving first line chemotherapy... Relevant subgroups and overall survival will be investigated." The stock tanked. Then 6 months later "Immutep Reports Statistically Significant Survival Benefit for Key Patient Groups in the Ongoing Phase IIb AIPAC Study in Metastatic Breast Cancer" Data with immune therapy improves over time. At 5 years we saw the only survivors in the PD L study were in the treatment groups. I suspect we will see the same with eftilagimod.

In Novemeber 2020, before the latest AIPAC results were known, Immutep announces a new license and collaboration with Labcorp, "with further potential commercial milestones and services payments." Not only can Immutep generate profits with Labcorp but this agreement allows Immutep to find those patients who will benefit from eftilagimod! The advantages of eftilagimod treatment will be seen sooner than in the original AIPAC study as the eftilagimod non responders are eliminated.

Approval should occur quickly for an effective and safer treatment. Maybe 24 months.

Expand

Yes we are in the biggest double blind study in human history.. data collected on mRNA technology... from all jurisdictions... so to speak....

"Buggy Lamp" for Bundaone... listen to an interview with one of the pioneers of mRNA (vac) tech on trialsitenews... very "irradiating" especially for the rats...

https://trialsitenews.com/dr-robert-malone-inventor-of-mrna-technology-discusses-the-spike-protein-interview/

yes all trial outcomes from around the globe, will be included in the FDA's system of evaluating a "novel therapy that may well be given orphan drug status"... now that is a Boom...

I may seem like a Putz, at least I am not the personification of Tutankhamun... king of????.... ('s)

a video youtube has not banned..... a good cover .....

IMM Price at posting: 52.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

NIM

Nimy extends sulphide targets at Mons with new anomalies identified

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

NXM

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

SFX

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

First 24 Last

Add IMM (ASX) to my watchlist

(20min delay)
Last 33.5¢		Change -0.100(23.0%)		Mkt cap ! $486.6M

Open	High	Low	Value	Volume
39.0¢	40.0¢	23.0¢	$16.23M	50.19M

Buyers (Bids)

No.	Vol.	Price($)
4	704297	33.0¢

Sellers (Offers)

Price($)	Vol.	No.
33.5¢	102135	2

View Market Depth

No.	Vol.	Price($)
4	704297	0.330
6	95226	0.325
8	320688	0.320
5	96798	0.315
5	162491	0.310

Price($)	Vol.	No.
0.335	102135	2
0.340	75209	1
0.345	172909	5
0.350	167499	5
0.355	93526	4

Last trade - 16.10pm 27/06/2024 (20 minute delay)

IMM (ASX) Chart

Yes we are in the biggest double blind study in human history.....

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Nimy extends sulphide targets at Mons with new anomalies identified

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes we are in the biggest double blind study in human history.....

Top Stories

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Nimy extends sulphide targets at Mons with new anomalies identified

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News